The Leukemia Program is a highly interdisciplinary group of investigators dedicated to reducing the incidence and subsequent mortality of Leukemia. The program fosters interdisciplinary research in basic science, genetics, clinical medicine, cancer prevention, and epidemiology at Fred Hutch, the faculty at the University of Washington, and the clinical community to improve leukemia prevention, detection, diagnosis and treatment. 

Program Strengths

Forty years ago, researchers at Fred Hutch developed bone marrow transplantation, which continues to be one of the most effective options for patients with Leukemia. Dr. E. Donnall Thomas and his team proved it is possible to replace cancerous cells and stem cells with donated healthy cells that engraft within a patient’s bone marrow. The discovery has created an effective treatment option for leukemia and other blood cancers, and earned Thomas the 1990 Nobel Prize in physiology or medicine.

leukemia graphic

Dr. Jerry Radich
STTR Leukemia Deputy Director

Dr. Radich is a medical oncologist who specializes in molecular genetics of leukemia. Dr. Radich studies why patients respond or relapse after therapy, and his lab also develops methods to detect minimal residual disease, as well as devising methods that can be used in the developing world.

Learn more at the Radich Lab